Jump to content

Taxotere shows good results in non-small cell lung cancer


Recommended Posts

PARIS, Sep. 4, 2007 -- Pharmaceutical company Sanofi-Aventis said seven trials of its Taxotere drug in treating non-small cell lung cancer showed a 'significant' improvement in overall survival rates versus existing treatments.

Taxotere, an anti-cancer agent used in other treatments, is the company's fourth best-selling drug.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.